Tag: Financial Results
HealthCare Global Enterprises reports 14% revenue growth and 59% PAT increase...
HCG’s financial results for Q1 FY25 show INR 5,256 million in revenue, INR 929 million in EBITDA, and significant profit growth
Metropolis Healthcare reports 13.1% revenue growth in Q1 FY25
The company achieves INR 313.4 crores in revenue, sees improved EBITDA margins of 25.0%, and PAT margins of 12.2%
Medanta posts ₹8,830 million revenue in Q1 FY2025 with plans for...
Consolidated total income rises 11.1%; EBITDA surges up by 4.5% with EBITDA margins at 23.6% highlighting new advancements across facilities
Praj Industries reports ₹6,991.41 million revenue for Q1 FY25
Profit After Tax soars to ₹841.80 million, fueled by strategic innovations, robust order bookings, and successful product developments
Lupin’s revenue climbs 16.3% to INR 55,143 million in Q1 FY2025
Lupin Limited posts impressive gains with EBITDA rising by 48.9% and profit after tax nearly doubling compared to the previous year
Indegene reports revenue over INR 2,500 crores for FY24
Indegene Limited posts strong financial growth with a 12.3% increase in revenue, a 28.6% rise in EBITDA, and a 26.5% surge in profit after tax, driven by robust operations and strategic client partnerships
Fortis reports 9.5% revenue growth in FY24
Fortis sees significant growth in hospital and diagnostics businesses, recommends dividend of Rs 1 per share, and strengthens NCR presence with new 450-bed hospital acquisition
Morepen Labs reports 143% surge in profit during FY24
FY24 witnesses a 20% increase in revenue, Dr. Morepen medical devices sales skyrocket by 35% as company marks 40 years
Metropolis Healthcare reports 15% growth in core revenue in Q4FY24
The company’s key highlights include a surge in patient volume by 9% and strong B2C revenue growth
Biocon’s biosimilars revenue crosses milestone of US $1 Billion in FY...
The company garnered an overall revenue of Rs 15,621 Crore in FY24, marking a remarkable 35% growth compared to the previous year